BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2016
View Archived Issues
First viable murine model of cblC type CMAH reported
Read More
Biallelic mutations in PPA2 are associated with mitochondrial dysfunction
Read More
Highland Therapeutics enters agreement for IBD drug candidate
Read More
Novel ciclosporin formulation PADciclo may allow lower doses for treating dry eye
Read More
Durable responses seen with oncolytic adenovirus CG-0070 in phase II/II bladder cancer trial
Read More
Australian institutions sign MOU to establish Australian Hepatitis C Elimination Program
Read More
Anti-sFlt-1 MAb preserves normal lung structure and prevents pulmonary hypertension in models of BPD
Read More
Merck & Co. receives positive opinion for Zepatier in the E.U.
Read More
Checkpoint Therapeutics signs BET inhibitor license agreements with Jubilant and TG Therapeutics
Read More
Humira receives CHMP positive opinion to treat certain forms of noninfectious uveitis
Read More
ConverGene patents inhibitors of bromodomain-containing proteins
Read More
H. Lundbeck discloses BACE1 inhibitors
Read More
FORGE Life Science develops antivirals
Read More
Romark Laboratories presents prodrugs of tizoxanide
Read More
FDA approves Zinbryta as once-monthly treatment for relapsing MS
Read More
Shanghai Shaletech Technology announces EGFR inhibitors
Read More
EMA begins review of guidelines governing first-in-human trials
Read More
European Commission approves Strimvelis for ADA-SCID
Read More
FDA grants accelerated approval to Ocaliva for primary biliary cholangitis
Read More
EMA's CHMP gives positive opinion on brentuximab vedotin for post-transplant Hodgkin's lymphoma
Read More
FDA approves Axumin to detect recurrent prostate cancer
Read More
EMA committee does not support approval of Ninlaro capsules
Read More
EMA committee recommends approval of Epclusa for hepatitis C
Read More
Saxagliptin/dapagliflozin receives positive opinion in E.U.
Read More
EMA committee hands down positive opinion to extend Kyprolis indication
Read More
FDA grants orphan drug designation to Portage's BHV-4157
Read More